Additionally, GO enrichment analysis revealed that several immune-related pathways are positively correlated with IDO1 expression in HNSCC, such as response to type I interferon and lymphocyte-mediated immunity pathways. The gene discussed is IDO1; the disease is head and neck squamous cell carcinoma.